Recent advances in genetics and genomics have unveiled numerous cases of autism spectrum disorders (ASDs) associated with rare, causal genetic variations. These findings support a novel view of ASDs in which many independent, individually rare genetic variants, each associated with a very high relative risk, together explain a large proportion of ASDs. Although these rare variants impact diverse pathways, there is accumulating evidence that synaptic pathways, including those involving synaptic cell adhesion, are disrupted in some subjects with ASD. These findings provide insights into the pathogenesis of ASDs and enable the development of model systems with construct validity for specific causes of ASDs. In several neurodevelopmental disorders frequently associated with ASD, including fragile X syndrome, Rett syndrome and tuberous sclerosis, animal models have led to the development of new therapeutic approaches, giving rise to optimism with other causes of ASDs.
Recent advances in the genetics of autism Autism and autism spectrum disorders (ASDs) are neurodevelopmental disorders with characteristic behavioral abnormalities, including deficits in reciprocal social interactions and communication, and the presence of repetitive behaviors and/or restricted interests. Onset occurs during the first three years of life and there is a male preponderance, with a sex ratio of 4:1. The incidence of ASDs is now estimated at 6 in 1000 [1] . Family and twin studies have demonstrated that ASDs have a very high heritability. ASDs are etiologically heterogeneous, with an underlying genetic disorder identified in 10-25% of cases, including monogenic disorders (e.g. fragile X syndrome [FXS] , tuberous sclerosis and Rett syndrome), chromosomal aberrations and genomic imbalances [2] . It has been widely assumed that the remaining cases for which a causal factor has not been identified (referred to as 'idiopathic' ASDs) are the result of interactions of multiple genetic variants of weak effect. This has led to the use of linkage and association studies to identify potential susceptibility loci of weak effect, few if any of which, however, have been consistently replicated [2] .
Recent technological developments, including advances in the detection of copy number variations (CNVs) (deletions and duplications) and rare point mutations, have begun to alter the conceptualization of ASDs, given that the results indicate that an ever increasing proportion of ASDs are due to rare, causal, single locus genetic changes that can be either inherited or de novo in origin. Recent findings point to the existence of many distinct autism loci, with de novo CNVs and mutations having important roles (de novo CNVs have been identified in 10% of sporadic cases and in 2-3% of families having two or more affected children [3, 4] ). The proportion of ASDs attributed to causal loci is likely to increase with the use of higher resolution microarrays and high-throughput sequencing.
This conceptual shift in ASDs can be summarized as a move from a 'common disease-common variant' perspective to a 'multiple rare variants' perspective (Box 1). The multiple rare variants model in ASD is reminiscent of the current conceptualization of intellectual disability (ID) [5, 6] , in which defects in many different genes cause a similar behavioral phenotype. In fact, numerous genetic syndromes that cause ID can also present with ASD, suggesting the existence of common pathways in these two disorders. More broadly, variation in a given locus can lead to other neuropsychiatric disorders beyond ASDs and ID, suggesting that clinical diverse phenotypes might share similar genetic underpinnings.
Interestingly, many of the rare variants identified in ASDs relate to synaptic cell-adhesion molecule (CAM) pathways, shedding light on the pathogenesis of ASDs and contributing to the identification of further candidate
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